Levilimab (IMAGE) BIOCAD Caption On June 5th, the Ministry of Health of the Russian Federation registered the original drug Levilimab (trade name Ilsira), intended for the treatment of harsh complications of coronavirus infection -- a cytokine storm. Levilimab is developed and produced by Russian biotechnology company BIOCAD. Credit BIOCAD Usage Restrictions None License Licensed content Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.